Golimumab API is a premium-quality recombinant human monoclonal antibody that selectively binds to Tumor Necrosis Factor-alpha (TNF-α), a key inflammatory cytokine involved in autoimmune and chronic inflammatory diseases. By neutralizing TNF-α, Golimumab reduces inflammation, prevents tissue damage, and improves clinical outcomes in patients with immune-mediated disorders.
Golimumab is widely indicated for the treatment of Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Ankylosing Spondylitis (AS), Ulcerative Colitis (UC), and other chronic inflammatory conditions. It is administered by subcutaneous injection or intravenous infusion depending on the therapeutic indication.
Swapnroop Drugs and Pharmaceuticals manufactures premium-quality Golimumab API under stringent WHO-GMP manufacturing standards. Every batch undergoes rigorous testing for purity, potency, sterility, biological activity, and stability. Complete regulatory documentation, including Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), and technical specifications, is available.
Golimumab API is supplied in validated sterile pharmaceutical packaging suitable for commercial manufacturing and clinical applications.
Available Packaging Options:
Each shipment includes:
Golimumab API is used for the treatment of autoimmune diseases including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis.
Golimumab binds to and neutralizes TNF-α, reducing inflammation and preventing immune-mediated tissue damage.
It belongs to the TNF-α inhibitor class of recombinant human monoclonal antibodies.
Yes. We provide Certificate of Analysis (CoA), Material Safety Data Sheet (MSDS), technical specifications, and complete regulatory documentation.
Yes. We offer commercial bulk quantities with reliable worldwide export support.
Get Bulk Quote via WhatsApp